Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer's Disease”

378 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 378 results

Testing effectiveness (Phase 2)Study completedNCT00722046
What this trial is testing

Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 198
Testing effectiveness (Phase 2)Study completedNCT01466088
What this trial is testing

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

Who this might be right for
Alzheimer's Disease
Targacept Inc. 386
Large-scale testing (Phase 3)Ended earlyNCT00550420
What this trial is testing

Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 331
Early research (Phase 1)Study completedNCT02386306
What this trial is testing

Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GliaCure, Inc. 39
Large-scale testing (Phase 3)Looking for participantsNCT06976216
What this trial is testing

Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 586
Testing effectiveness (Phase 2)Study completedNCT00663936
What this trial is testing

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
FUJIFILM Toyama Chemical Co., Ltd. 373
Not applicableUnknownNCT04021888
What this trial is testing

The Effects of Exercise Program in Alzheimer's Patients With Mild to Moderate Stage Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAerobic ExerciseBreathing Exercise+1 more
Dokuz Eylul University 60
Large-scale testing (Phase 3)Study completedNCT04994483
What this trial is testing

Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 804
Not applicableStudy completedNCT04404153
What this trial is testing

Neurostimulation for Cognitive Enhancement in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia
Albert Einstein College of Medicine 100
Testing effectiveness (Phase 2)UnknownNCT00606164
What this trial is testing

Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Blanchette Rockefeller Neurosciences Insitute 9
Testing effectiveness (Phase 2)Ended earlyNCT00895895
What this trial is testing

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

Who this might be right for
Alzheimer Disease
Pfizer 526
Not applicableStudy completedNCT00348309
What this trial is testing

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 1,496
Early research (Phase 1)Study completedNCT00633841
What this trial is testing

Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Affiris AG 24
Not applicableStudy completedNCT00211159
What this trial is testing

OmegAD (Omega-3 and Alzheimer's Disease)

Who this might be right for
Alzheimer's Disease
Karolinska University Hospital 204
Large-scale testing (Phase 3)Study completedNCT04488419
What this trial is testing

ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia of Alzheimer Type
LeonaBio 554
Testing effectiveness (Phase 2)Study completedNCT01009255
What this trial is testing

Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 196
Testing effectiveness (Phase 2)Ended earlyNCT06185543
What this trial is testing

A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.

Who this might be right for
Alzheimer Disease
NeuroSense Therapeutics Ltd. 8
Post-approval studies (Phase 4)Ended earlyNCT01181921
What this trial is testing

The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen-Cilag, S.A. 1
Large-scale testing (Phase 3)Ended earlyNCT00679627
What this trial is testing

Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Janssen Research & Development, LLC 2,051
Testing effectiveness (Phase 2)Study completedNCT00104273
What this trial is testing

Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
DementiaAlzheimer's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 376
Load More Results